[
  {
    "criterion": "Provides a clear and concise overview of the differences between insulin aspart and insulin lispro in prepubescent children with type 1 diabetes.",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Incorrectly states that insulin glulisine is a long-acting insulin analog.",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Asks the user what they would like to know about insulin aspart vs lispro in prepubescent children with type 1 diabetes to seek more relevant context.",
    "axis": "context_awareness",
    "point": 6
  },
  {
    "criterion": "Provides a detailed explanation of the pharmacodynamics, efficacy, and safety profile of insulin aspart and insulin lispro in prepubescent children with type 1 diabetes.",
    "axis": "completeness",
    "point": 10
  },
  {
    "criterion": "Fails to mention the importance of monitoring blood glucose trends when switching between insulin analogs.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Provides a clear and concise explanation of the side-effect profiles of insulin aspart, lispro, and glulisine in pediatric patients.",
    "axis": "communication_quality",
    "point": 9
  },
  {
    "criterion": "Incorrectly states that insulin glulisine is interchangeable with insulin aspart and insulin lispro in pediatric populations.",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Provides a comprehensive overview of the clinical monitoring and management of insulin analogs in prepubescent children with type 1 diabetes.",
    "axis": "completeness",
    "point": 10
  },
  {
    "criterion": "Fails to mention the potential for weight gain in some children when using insulin analogs.",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Provides a clear and concise explanation of the practical considerations for choosing between insulin aspart, lispro, and glulisine in prepubescent children with type 1 diabetes.",
    "axis": "communication_quality",
    "point": 8
  }
]